Virpax Pharmaceuticals, Inc. (VRPX)
NASDAQ: VRPX · IEX Real-Time Price · USD
0.530
+0.029 (5.81%)
At close: Jul 2, 2024, 4:00 PM
0.524
-0.006 (-1.15%)
After-hours: Jul 2, 2024, 6:50 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $1.45 million as of July 2, 2024. Its market cap has decreased by -87.99% in one year.
Market Cap
1.45M
Enterprise Value
-412.81K
1-Year Change
-87.99%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since the IPO on February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from $45.09M to $1.45M, a decrease of -96.78%. That is a compound annual growth rate of -63.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 600.00K | -83.78% |
| Dec 29, 2023 | 3.70M | -49.32% |
| Dec 30, 2022 | 7.30M | -81.84% |
| Dec 31, 2021 | 40.20M | -10.84% |
| Feb 17, 2021 | 45.09M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seelos Therapeutics | 1.71M |
| Galmed Pharmaceuticals | 1.65M |
| Scinai Immunotherapeutics | 1.62M |
| 180 Life Sciences | 1.55M |
| Salarius Pharmaceuticals | 1.42M |
| NeuBase Therapeutics | 1.42M |
| Dynatronics | 1.41M |
| eFFECTOR Therapeutics | 1.36M |